MXiPr, a Dissociatives, and 3-MeO-PCP, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 44 documented effects in common, with 9 effects unique to MXiPr and 23 unique to 3-MeO-PCP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Effects | 53 documented | 67 documented |
| Interaction | Caution | |
| Level | MXiPr | 3-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 1 mg |
| Light | 10–20 mg | 2–5 mg |
| Common | 20–40 mg | 5–10 mg |
| Strong | 40–60 mg | 10–15 mg |
| Heavy | 60 mg | — mg |
| Level | MXiPr | 3-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 2 mg |
| Light | 10–20 mg | 4–8 mg |
| Common | 20–40 mg | 8–15 mg |
| Strong | 40–60 mg | 15–25 mg |
| Heavy | 60 mg | 25 mg |
| Level | Dose |
|---|---|
| Threshold | 2 mg |
| Light | 5–10 mg |
| Common | 10–20 mg |
| Strong | 20–25 mg |
| Heavy | 25 mg |
MXiPr
3-MeO-PCP
MXiPr
3-MeO-PCP
Compounding dissociative effects can cause confusion, mania, and loss of motor control